Clinical Trial Update: The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention [Phase 2]

View source ↗

Summary

Phase 2 trial in acute urinary retention assessing pyridostigmine addition to silodosin in prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Pyridostigmine (pyridostigmine)
• Silodosin (Silodosin)

Snippet

Sponsor: Beni-Suef University | Conditions: Prostatic Hyperplasia | Phase 2 | Status: COMPLETED